Acute Myeloid Leukemia
Patients in the remission induction stage
Versandkostenfrei!
Versandfertig in 6-10 Tagen
29,99 €
inkl. MwSt.
PAYBACK Punkte
15 °P sammeln!
Acute myeloblastic leukemias (AML) constitute between 15% and 20% of leukemias in pediatric patients. In order to describe patients diagnosed with acute myeloid leukemia in the remission induction stage, a descriptive, cross-sectional study was carried out in patients diagnosed with acute myeloid leukemia at the University Pediatric Hospital "José Luis Miranda" of Santa Clara. We worked with 24 patients. Almost all of them presented anemia, leukocytosis and thrombocytopenia. The main complications were sepsis and febrile neutropenia, which showed no association with sex or age of the patients...
Acute myeloblastic leukemias (AML) constitute between 15% and 20% of leukemias in pediatric patients. In order to describe patients diagnosed with acute myeloid leukemia in the remission induction stage, a descriptive, cross-sectional study was carried out in patients diagnosed with acute myeloid leukemia at the University Pediatric Hospital "José Luis Miranda" of Santa Clara. We worked with 24 patients. Almost all of them presented anemia, leukocytosis and thrombocytopenia. The main complications were sepsis and febrile neutropenia, which showed no association with sex or age of the patients. Hyperleukocytosis was present in obese patients and cardiotoxicity predominated in overweight and obese patients.
Andere Kunden interessierten sich für
